Working for better medicine

We are committed to improving healthcare by researching and developing innovative solutions for disease prevention, management and cure.

An overview of [add local affiliate name]

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia.

0 K

Lorem ipsum dolor sit amet, consectetur adipiscing elit

0 K

Lorem ipsum dolor sit amet, consectetur adipiscing elit

0 K

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Therapeutic Areas

Here’s where our expertise brings effectiveness.
Our expertise in developing effective treatments enables us to address complex challenges in key therapeutic areas.

Italfarmaco SpA - Rare Diseases
Italfarmaco SpA - Women's Health
Italfarmaco SpA - Cardiometabolic
Italfarmaco SpA - Neurology Psychiatry
Thrombosis and Critical Ischemia
Italfarmaco SpA - Cunsomer Health

Our History

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.

Meet our Leaders

Francesco De Santis, Chairman Italfarmaco SpA

Francesco
De Santis

Chairman
Italfarmaco

Bio
Carlos Barallobre, CEO Italfarmaco SpA

Carlos
Barallobre

CEO
Italfarmaco

Bio

Name
Surname

Country Manager [add local affiliate name]

Bio

Evolution: how to make treatments more accessible for more patients

Pharmaceutics is a dynamic science, constantly evolving to make every medicine, formula, and application more effective. Our commitment to accessibility drives us to provide significant benefits and enable more people to access targeted and effective treatments. In our four research hubs, we focus on identifying new dosing solutions for approved drugs, repurposing reformulations, and developing APIs to deliver high-quality generic medicines to the market, ensuring that healthcare is more inclusive.

News & Highlights

Lorem ipsum dolor sit amet, consectetur adipiscing elit

  • 2024 - June 28

    Italfarmaco partners with Iktos on Artificial Intelligence to speed drugdiscovery breakthroughs for patients

    Combines AI to increase the potential of novel histone deacetylase (HDAC) inhibitors in the non-oncological field

  • 2023 - September 7

    Duchenne Awareness DAY 2023

    7 September marks World Duchenne Awareness Day (WDAD), a disease in which we as a company are particularly involved.

  • 2022 - September 7

    Duchenne Awareness DAY 2022

    September 7th is World Duchenne Muscular Dystrophy Awareness Day, a disease that sees us, as a company, at the forefront of the search for a drug that can slow down its progression.

  • 2022 - July 26

    Italfarmaco acquires 100% of Lacer, a Spanish pharmaceutical company that is a leader in health care and personal hygiene

    Thanks to this operation, that is subject to the approval of the competition authorities, the Group will reach 1,300 employees in Spain and 3,500 globally, with a consolidated turnover of over 1 billion euros.